Literature DB >> 22783567

MicroRNAs in health and disease--basic science and clinical applications.

Abdimajid Osman1.   

Abstract

MicroRNAs (miRs) are small RNAs that fine-tune gene expression at posttranscriptional level. They are involved in virtually all physiological processes, such as development and differentiation, heart function, metabolism, haemostasis, and apoptosis. Anucleated human platelets were revealed to contain comparatively many different miR species relative to nucleated cells, suggesting a functional impact of miRs on these small cells. In recent years, numerous studies have established the significance of miRs in different physiological states. Sufficient evidence exists to suggest that miRs are involved in a range of diseases, including cancer and cardiovascular disorders. Aberrant expression levels of miRs are found in tissues and in sera from patients with different forms of malignant tumours. Utilising these miRs as biomarkers for disease is a valuable diagnostic strategy. In addition, a novel class of synthetic oligonucleotides, called antagomirs, has recently been introduced as efficient silencers of overexpressed miRs in cancer. Overall, miRs represent an important class of small RNAs with a huge impact on health and disease. Future studies will further illuminate the potential value of miRs in diagnostics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783567

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  54 in total

1.  Expression of miR-221 in colon cancer correlates with prognosis.

Authors:  Ke Cai; Feng Shen; Jun-Hui Cui; Yong Yu; Hai-Qiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.

Authors:  Haiqing Cai; Lijun Lin; Haikang Cai; Mingjie Tang; Zhigang Wang
Journal:  Med Oncol       Date:  2013-02-22       Impact factor: 3.064

Review 3.  Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.

Authors:  Vera Paschon; Silvia Honda Takada; Juliane Midori Ikebara; Erica Sousa; Reza Raeisossadati; Henning Ulrich; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

4.  Prediction of human miRNA target genes using computationally reconstructed ancestral mammalian sequences.

Authors:  Mickael Leclercq; Abdoulaye Baniré Diallo; Mathieu Blanchette
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

5.  Long Non-coding RNA MALAT1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124.

Authors:  Hongyu Cheng; Haikang Zhao; Xin Xiao; Qian Huang; Wen Zeng; Bo Tian; Tao Ma; Dan Lu; Yulong Jin; Yuqian Li
Journal:  Mol Neurobiol       Date:  2020-10-19       Impact factor: 5.590

6.  Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4.

Authors:  Hao Xu; Heng Cao; Guoqing Zhu; Shaowen Liu; Hongli Li
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.

Authors:  John D Clarke; Tatiana Sharapova; April D Lake; Eric Blomme; Jonathan Maher; Nathan J Cherrington
Journal:  J Appl Toxicol       Date:  2013-11-12       Impact factor: 3.446

8.  MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.

Authors:  Weiping Chang; Lei Zhang; Yao Xian; Zhaoxiang Yu
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

9.  miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.

Authors:  Xingyu Lin; Zhiguang Yang; Peng Zhang; Yunpeng Liu; Guoguang Shao
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

10.  Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes.

Authors:  Huaping Shi; Lei Chen; Huilan Wang; Shoukang Zhu; Chunming Dong; Keith A Webster; Jianqin Wei
Journal:  Biochem Biophys Res Commun       Date:  2012-11-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.